ABBV vs CLPT · P/E 81, rev $16.99B vs rev $31.4M
AbbVie Inc (ABBV) versus Clearpoint Neuro Inc (CLPT) — a side-by-side from cached financials, not a winner call.
AbbVie Inc (ABBV) is a drug manufacturers - general company listed on US. It is led by Rob Michael.
Clearpoint Neuro Inc (CLPT) is a medical devices company listed on US.
Latest reported ABBV revenue for 2026-06-30 was $16.99B. Net income was $3.61B. Revenue was up 13.3% from 2026-03-31 to 2026-06-30. ABBV currently screens at market cap $334.34B and trailing P/E 80.5.
Latest reported CLPT revenue for 2024-12-31 was $31.4M. Net income was -$18.9M. Revenue was up 31.0% from 2023-12-31 to 2024-12-31. CLPT currently screens at market cap $371.0M.
ABBV currently screens at market cap $334.34B and trailing P/E 80.5. CLPT currently screens at market cap $371.0M.
Not investment advice. Open the ABBV and CLPT stock pages for the full models.
Not investment advice.